US3715281A - Transgrow - Google Patents

Transgrow Download PDF

Info

Publication number
US3715281A
US3715281A US3715281DA US3715281A US 3715281 A US3715281 A US 3715281A US 3715281D A US3715281D A US 3715281DA US 3715281 A US3715281 A US 3715281A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
medium
agar
percent
growth
proteus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
J Martin
A Lester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services (HHS)
Original Assignee
US Department of Health and Human Services (HHS)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12Nitrate to nitrite reducing bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/80Elimination or reduction of contamination by undersired ferments, e.g. aseptic cultivation

Abstract

An improved transport vehicle for N. gonorroheae and N. meningitidis utilizing under a 10% CO2 blanket, a growth medium which utilizes as essential components an improved hard agar concentration of about 2.0-2.5 percent twinned with about 0.25 percent dextrose. A diamino benzyl pyrimidine to selectively screen out Proteus may be added.

Description

United States Patent 1 1 Martin, Jr. et al.

[ 51 Feb.6, 1973 1 TRANSGROW [75] Inventors: John E. Martin, Jr.; Arzell Lester,

both of Atlanta, Ga.

[73] Assignee: The United States of America as represented by the Secretary of the Department of Health, Education and Welfare [22,] Filed: Oct.23, 1970 i 21 Appl.No.: 83,169

[52] US. Cl ..195/104, 195/100 [51] Int. Cl. ..Cl2k 1/00, C12b 3/00 [58] Field of Search ..195/99, 100, 101, 102, 103

[56] References Cited UNITED STATES PATENTS 2,970,948 2/1961 Stevens .,l95/100X OTHER PUBLICATIONS Breed et al.; Bergeys Manual of Determinative Bact., 7th Ed Williams & Wilkins C0., pg. 481-483, 1957 Hitchings ..260/256.4

Primary Examiner-A. Louis Monacell Assistant Examiner-Robert J. Warden 'Att0rney-.lohn S. Roberts, Jr. and Norman J. Latker 57 ABSTRACT 3 Claims, N0 Drawings Cooper ..195/100 X TRANSGROW The present invention relates to a method and composition for a transport-growth medium, particularly adapted to permit a specimen of pathogenic Net'sseria to be taken from the patient and transported to a remote laboratory for analysis.

This invention is particularly adapted to utilization with N. gonorrhoeae and N. me'ningitidis and is particularly useful to combat the wave of untreated and drugresistant strains of these organisms by identification in central laboratories remote from a patient located in rural or semi-urban territories.

In the prior art, one major problem in developing a successful growth medium which will harbor the gonococcus and meningicoccus has been that in the culture method utilized there developed an overgrowth or contamination with other bacteria which surpassed the slowly developing gonococci, for example, and make identification difficult or impossible. In the methodology of these mediums, the present inventor has been known as a co-developer in the so-called Thayer-Martin medium of which the present invention is a refinement and in its optimum variety, specially targeted towards overcoming the problem of competing bacteria in the medium. The literature prior art into which this invention falls is reflected by the following:

1. James D. Thayer and John E. Martin, A Selective Medium for the Cultivation of N. gonorrhoeae and N. meningitidis, PHR 79, pages 4957, 1964.

2. James D. Thayer and John E. Martin, Improved Medium Selective for Cultivation of N. gonorrhoeae and N. meningitidis, PHR 81, pages 559-561, I966, 1

3. Martin et al., Primary Isolation of N. gonorrhoeae with a New Commercial Medium, PHR 82, pages 36l363, I967.

The previous compositions, such as the basic Thayer- Martin medium, although containing other additive nutrients, were based upon an agar concentration which was about 1 percent by weight. In this concentration, it was found that the agar was insufficient in quantity for optimum nutrition of the gonococci and, further, that when the agar set in a semi-gel it easily permitted the insertion of the swab into the body of the agar rather than encouraging the physician to roll the specimen swab along the top surface for better results. Therefore, in the present compositions the agar percentage has been raised to about 2.0-2.5 percent and the improved results achieved have also been increased by addition of a specific but minor amount of dextrose, i.e., 0.25 percent by weight.

Finally, in order to screen out other gram-positive and gram-negative bacteria, principally from the Proteus family, the present invention utilizes a 2,4- diamino-S-benzyl pyrimidine to screen out the offending Proteus causing overgrowth. More particularly, the present invention utilizes two related compounds, namely 2,4-diamino-5-(34-dimethoxybenzyl)- pyrimidine which is Diaveridine (Burroughs Wellcome and Company) and 2,4-diamino-5-(3'4'5'-trimethoxybenzyl)-pyrimidine which is Trimethoprim (Burroughs Wellcome and Company).

THE SUBJECT MICROORGANISM The microorganisms which this invention is designed to transport and grow (TRANS-GROW) as a medium are N. gonorrhoeue (the gonococcus) and N. meningitidis' (the meningicoccus) which are species of Net's-- seria, and both are rather small gram-negative diplococci characterized by a cell having somewhat the shape of a coffee bean. The Net'sseria family are aerobic, and grow well at 34-37C. Frobisher observes, in his Fundamentals of Microbiology," VII, I965, page 449 (Saunders), that the two varieties are very much alike and one is probably a minor variant of the other. Additionally, both are extremely fragile in the outer world and grow best upon an agar with 5-10% CO especially a blood agar or chocolate agar.

Thus, in recognition of the preferred CO bIanket over the nutrient, a preferred modus for transportation consists of a l-ounce flat specimen bottle with an airtight rubber top which has been filled with l0% CO /9O% air mixture. A convenient method of providing a C0 atmosphere for the specimen may be in accordance with the procedure of US. Pat. No. 2,706,702, Carski.

THE COMPETING MICROORGANISMS Although in the case of N. gonorrhoeae various other microorganisms present in the g.u. tract may introduce growth overlay complications, it has been found that the principal source of difficulty lies in the genus Proteus which are soil and water saprophytes found in the human intestine and in infections in the urinary and intestinal tract. In this genus, the H. and O. colonies of many strains of Proteus are distinctive in that they usually spread rapidly over the moist surface of solid media forming a thin, grey, almost transparent film. Two species, P. vulgaris and P. mirabilis, produce hydrogen sulfide rapidly and swarm on moist agar media (from Smith Conant, Overman, Microbiology, XIII, page 618, I964, Appleton). It is to be noted that the frequency of Proteus in the urinary tract is pointed up by the fact that Proteus, next to E. coli, produce the most infections in the urinary tract.

TRANS-GROW MEDIUM Agar Agar in the art generally refers to a strongly gelling seaweed hydrocolloid characterized by low ester sulfate content. The basic repeating unit of agar consists of alternating 1,3-linked B-D-galactopyranose and 1,4-linked 3,6-anhydro-a-L-galactopyranose units. This substance has been utilized as a solid culture medium since about 1882.

In the development of culture media since the latter part of the 19th Century, many substances have been added to agar to ameliorate or change its growth potential. The so-called chocolate agar and variations were made from dried blood, and dried and processed hemoglobin has been substituted for the blood content of the chocolate agar. Dorland defines chocolate agar as follows: agar to which fresh blood has been added and which is then heated, the red blood changing to a chocolate brown color." (Dorlands Illustrated Medical Dictionary, XXIV, I965, Saunders). A chocolate agar is most preferred of the agars utilizable in the present invention.

It has been found that an increase in the agar concentration from about 1 percent as previously utilized to about 22.5 percent preferred for the present invention is further assisted by the addition of a minor but essential amount of dextrose-about 0.25 percent by weight.

It is noted that in the Thayer-Martin description, at least two agar base media are utilized with additives, and in particular PHR 82, page 361, 1967 ante, is incorporated by reference, together with the two base media utilized, namely Difco Chocolate Medium, Difco Laboratories, Detroit, Michigan, and BBL Chocolate Medium, Baltimore Biological Laboratories, Baltimore, Maryland.

It is noted that in the original Thayer-Martin description, circa 1964, that overgrowth by some gram positive and some other gram-negative bacteria and yeast was prevented because the medium contained 3.0 units of Vancomycin, 7.5 ug of Colistimethate sodium, and 12.5 units Nystatin, per ml. Additionally, the medium contained multi-vitamin growth promoters such as lsovitalex (Bioquest) or Supplement B (Difco).

The Proteus Screening Agent It has been known for some time that the Proteus microorganism was the chief miscreant which created optical films on the nutrient to forbid layer analysis of the desired N. gonorrhoeae and N. meningitidis. Recently, attention has been directed to the 2,4- diamino-S-benzyl pyrimidines for this purpose, and more particularly directed to two anti-bacterial compounds which have given superior results for screening out the offending Proteus. These compounds are 2,4- diamino-5-(3'4'5-trimethoxybenzyl)-pyrimidine, Trimethoprim (Burroughs Wellcome, U.S. Pat. No. 3,049,544, Stenbuck et al.) and 2,4-diamino-5-(34- dimethoxybenzyl)-pyrimidine, Diaveridine (Burroughs Wellcome, U.S. Pat. No. 2,624,732, Hitchings et al.). The concentration of the compound is quite specific in the medium, for example, for Trimethoprim a concentration of 5 micrograms per milliliter has been found optimum and for the Diaveridine a concentration of about 25 micrograms per milliliter has been found optimum. It is known that selective media for the isolation of a single bacterial species, e.g., gonococcus, from contaminated specimens, are seldom absolute. However, in this case, the growth of the desired organism is favored and the undesired Proteus is inhibited to a point where pure cultures may be much more easily isolated.

EXAMPLEI One thousand 1 oz. specimen bottles with rubber caps were utilized as a starting glass material. Into each bottle was inserted ml. of a 3 percent solution of BBL chocolate agar together with a 0.25 weight per cent dextrose, c.p. The bottles were stored in racks upright, and passed under a small gas injection machine which fed 10% CO and 90 percent air to fill the bottles. At the next index of a rotating machine, an antiseptic swab was taped to the bottle for specimengathering purposes and the growth medium was shipped to point of use with instructions to maintain the temperature of the bottle'at 34-37C. in an incubator for hrs. at the central diagnostic laboratory. At the laboratory, the agar surface was examined for growth of typical gonococcal and meningococcal colonies and identification was confirmed by conventional oxidase test and gram stain.

EXAMPLE 11 Five hundred 1 02. flat specimen bottles, previously sterilized and with rubber tops, were utilized as glass material. Into each bottle a 3 percent solution of Difco chocolate agar, 0.25 percent by weight dextrose and 5 micrograms Trimethoprim were added. The bottles were subsequently individually filled with a 10 percent CO blanket, capped, labeled, and provided with specimen applicators. A warning legend noted that the physician should keep the specimen bottle upright while obtaining a specimen to preserve the CO blanket and the laboratory should maintain the specimen at 3437C. for 20 hrs. to incubate the colonies.

EXAMPLE III EXAMPLE Vl Preparation and Use of Transgrow Medium Materials and Methods All media and supplements used throughout this study were those of Difco and Bioquest.

The stock cultures of bacteria used were obtained 10- cally. Suspensions of stock organisms were prepared by washing off the 20hours growth with Trypticase Soy Broth (T88) and diluting to give a 45 percent transmittance of light in a spectrophotometer (B & L spectronic 20, wavelength 530). The stock suspensions were diluted to 10' for testing.

Secretions from patients suspected of gonorrheal infection were obtained from the Fulton County Health Department, Atlanta, Georgia, and from the Norfolk City Health Department, Virginia. Each specimen was taken by cotton swab and placed in 1.0 ml of sterile TSB. The swabs were rotated and the excess fluid expressed against the side of the tube. To promote homogeneity of the suspension, the specimen was mixed by using a Vortex shaker. Two swabs were placed into the mixture, and one swab used to inoculate each of the media tested.

Twenty-five recent isolates of meningococci were furnished through Third U.S. Army Laboratory, Fort McPherson, Georgia.

The experimental medium for transport and growth (Transgrow) of Neisseria gonorrhoeae and Neisseria meningitidis was prepared as follows:

Mixture 1 CC Medium Base Agar 36.0 gms. Agar 10.0 gms. Distilled Water 500.0 ml. Mixture 2 Hemoglobin 10.0 grns. Distilled water 500.0 ml.

After the two mixtures were autoclaved (21C, 15 minutes) they were allowed to cool to 56C. Then, to Mixture 1 was added 10.0 ml of an enrichment [Supplement B (Difco) or Isovitalex (Bioquest)], 10 ml of an antibiotic supplement, and 6.0 ml of a sterile 25 percent dextrose solution. After thorough mixing, Mixture 1 was combined with Mixture 2.

then tightly fastened.

The medium was inoculated by briefly removing the screw cap and rolling the swab from side to side over the surface of the agar. During the inoculation procedure the mouth of the bottle was kept elevated to minimize the loss of C0 The caps were then replaced and tightened.

Following inoculation the bottles were placed in a urethane container (Phillips-Foscus Company) and mailed to the laboratory. Transit time varied from 48-96 hours. Upon receipt, the bottles were incubated for 16 hours and 35C. Oxidase-test reagents were applied to suspected colonies. Samples of oxidase-positive colonies were taken for gram-staining and subculturing for analysis by sugar fermentation. N. gonorrhoeae was said to be present if typical oxidase-positive colonies contained gram-negative diplococci and fermented glucose but not maltose.

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:

1. The process of transporting for analysis samples of gonorrhea and N meningitidis in the presence of a 10% CO blanket atmosphere contiguous to the growth medium and utilizing as essential active ingredients of said growth medium a combination of about 2.0-2.5 percent agar, 0.25 percent dextrose and an effective amount of a diamino bienzyl pyrimidine to screen out Proteus.

2. The improvement according to claim 1 wherein the growth medium contains about 5 p.g./ml. of 2,4- diamino-5(345-trimethoxybenzyl)-pyrimidine.

3. The improvement according to claim 1 wherein the growth medium contains about 25 pg/ml. of 2,4-

diamino-5-(3'4-dimethoxybenzyl)-pyrimidine.

Claims (2)

1. The process of transporting for analysis samples of gonorrhea and N meningitidis in the presence of a 10% CO2 blanket atmosphere contiguous to the growth medium and utilizing as essential active ingredients of said growth medium a combination of about 2.0-2.5 percent agar, 0.25 percent dextrose and an effective amount of a diamino bienzyl pyrimidine to screen out Proteus.
2. The improvement according to claim 1 wherein the growth medium contains about 5 Mu g./ml. of 2,4-diamino-5(3''4''5-trimethoxybenzyl)-pyrimidine.
US3715281A 1970-10-23 1970-10-23 Transgrow Expired - Lifetime US3715281A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US8316970 true 1970-10-23 1970-10-23

Publications (1)

Publication Number Publication Date
US3715281A true US3715281A (en) 1973-02-06

Family

ID=22176621

Family Applications (1)

Application Number Title Priority Date Filing Date
US3715281A Expired - Lifetime US3715281A (en) 1970-10-23 1970-10-23 Transgrow

Country Status (1)

Country Link
US (1) US3715281A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883396A (en) * 1973-03-30 1975-05-13 Jr Charles A Thomas Gonorrhea detecting
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
US5702944A (en) * 1994-07-25 1997-12-30 Micro Test, Inc. Microbial transport media

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
US2970948A (en) * 1953-10-22 1961-02-07 Sunkist Growers Inc Method of preparing dry culture media
US3098106A (en) * 1959-12-07 1963-07-16 Exxon Research Engineering Co Production of rocket fuel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970948A (en) * 1953-10-22 1961-02-07 Sunkist Growers Inc Method of preparing dry culture media
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
US3098106A (en) * 1959-12-07 1963-07-16 Exxon Research Engineering Co Production of rocket fuel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Breed et al.; Bergeys Manual of Determinative Bact., 7th Ed., Williams & Wilkins Co., pg. 481 483, 1957 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883396A (en) * 1973-03-30 1975-05-13 Jr Charles A Thomas Gonorrhea detecting
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
US5702944A (en) * 1994-07-25 1997-12-30 Micro Test, Inc. Microbial transport media

Similar Documents

Publication Publication Date Title
Lewin et al. Isolation, cultivation and characterization of flexibacteria
Wolinsky et al. Mycobacteria in soil and their relation to disease-associated strains
Groover et al. Phycological Studies--VIII. The Taxonomy and Comparative Physiology of the Chlorosarcinales and Certain Other Edaphic Algae
US3360440A (en) Cold water reconstitutable microbiological medium, process for preparation and use, ad product
Khairat The non-aerobes of post-extraction bacteremia
Thayer et al. A selective medium for the cultivation of N. gonorrhoeae and N. meningitidis
Bisharat et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel
Franklin et al. Studies on natural gastric flora: I. Bacterial flora of fasting human subjects
Riley et al. Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens.
Dahlén et al. A comparison of two transport media for saliva and subgingival samples
Lo et al. Newly discovered mycoplasma isolated from patients infected with HIV
Arret et al. Outline of details for microbiological assays of antibiotics: second revision
Aluotto et al. Standardized bacteriologic techniques for the characterization of Mycoplasma species1, 2
Tenney et al. Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia.
Wilson et al. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.
Karma et al. Bacteria in chronic maxillary sinusitis
Edward A selective medium for pleuropneumonia-like organisms
Young et al. Interactions of oral strains of Candida albicans and lactobacilli
Reyn Laboratory diagnosis of gonococcal infections
Hynes The isolation of intestinal pathogens by selective media
Frantz Jr Growth requirements of the meningococcus
Liu et al. Biological activities of pyochelins: iron-chelating agents of Pseudomonas aeruginosa.
Walsh et al. The laboratory diagnosis of melioidosis
Mossel Enumeration of sulphite‐reducing clostridia occurring in foods
Zinnemann et al. A new V‐dependent Haemophilus species preferring increased CO2 tension for growth and named Haemophilus paraphrophilus, nov. sp.